Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9000+0.0400 (+1.40%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
15
15
26.7938
25.6969
131.2127
Operating expenses
Research development
29,739
23,729
19,995
5,275
2,871
Selling general and administrative
10,443
9,735
6,680
2,503
2,011
Total operating expenses
39,603
32,957
26,132
7,299
4,652
Operating income or loss
-39,588
-32,942
-26,105
-7,273
-4,521
Interest expense
56
39
22.9662
3.671
8.7475
Total other income/expenses net
1,535
179
-1,421
341.4022
3,024
Income before tax
-37,376
-31,757
-26,385
-6,669
-1,442
Income tax expense
-
-
-
0
48.5089
Income from continuing operations
-37,376
-31,757
-26,385
-6,669
-1,490
Net income
-37,376
-31,757
-26,385
-6,669
-1,490
Net income available to common shareholders
-37,376
-31,757
-26,385
-6,669
-1,490
Basic EPS
-
-0.54
-0.56
-0.21
-0.09
Diluted EPS
-
-0.54
-0.56
-0.21
-0.09
Basic average shares
-
59,023
47,430
33,617
19,074
Diluted average shares
-
59,023
47,430
33,617
19,074
EBITDA
-
-31,539
-26,241
-6,666
-1,433